May 3rd 2024
Jaime R. Merchán, MD, discusses the future treatment of patients with advanced renal cell carcinoma.
March 28th 2024
Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.
February 27th 2024
Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.